Related Experiment Video
Updated: Sep 12, 2025

08:47
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.6K
Modular platform for therapeutic drug delivery using trifunctional bio-orthogonal macromolecular conjugates
Biorxiv : the Preprint Server for Biology
|August 8, 2025
Summary
Researchers developed a modular platform for creating bio-orthogonal macromolecular conjugates (BMCs). These conjugates enable targeted delivery of therapeutic macromolecules, overcoming key challenges in drug development and gene editing.
Area of Science:
- Bioconjugation Chemistry
- Drug Delivery Systems
- Molecular Therapeutics
Background:
- Targeted delivery of macromolecular therapeutics is crucial for advanced treatments like modulating protein-protein interactions and genome editing.
- Conventional small molecules face limitations, necessitating novel delivery strategies for larger therapeutic agents.
- Efficient, safe, and cell type-specific delivery of macromolecules remains a significant hurdle in biomedical research.
Purpose of the Study:
- To develop a versatile and modular platform for synthesizing heterotrifunctional bio-orthogonal macromolecular conjugates (BMCs).
- To engineer BMCs capable of targeted delivery, intracellular trafficking, and specific biological activities.
- To demonstrate the broad applicability of BMCs across various biomedical applications, including diagnostics and therapeutics.
Main Methods:
- Engineered heterotrifunctional bio-orthogonal macromolecular conjugates (BMCs) by combining targeting ligands, cell-penetrating peptides (CPPs), and bioactive cargos.
- Utilized facile bioconjugation chemistries to optimize BMC synthesis for yield, structural integrity, and activity.
- Assayed BMC utility through fluorescent cargo for endosomal escape, peptidomimetic inhibitors for anti-leukemic activity, and CRISPR-Cas9 for gene editing.
Main Results:
- Developed modular BMCs accommodating diverse components like antibodies, CPPs, optical probes, therapeutic peptidomimetics, and CRISPR-Cas9.
- Demonstrated successful endosomal escape and intracellular accumulation of fluorescently labeled BMCs.
- Showcased potent anti-leukemic activity of MYB inhibitor BMCs and efficient, cell type-specific gene editing with Cas9 BMCs in human cells.
Conclusions:
- The modular BMC platform enables customizable delivery of functional macromolecules.
- BMCs offer a broadly applicable solution for overcoming challenges in macromolecular drug delivery and targeted therapies.
- This approach facilitates precise modulation of cellular functions and holds significant promise for diverse biomedical applications.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
423
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
423
Drug Delivery: Miscellaneous Routes
468
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
468

